Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes.
Yu X, Ruan Y, Huang X, Dou L, Lan M, Cui J, Chen B, Gong H, Wang Q, Yan M, Sun S, Qiu Q, Zhang X, Man Y, Tang W, Li J, Shen T.
Yu X, et al.
Biochem Biophys Res Commun. 2020 Feb 26;523(1):140-146. doi: 10.1016/j.bbrc.2019.12.027. Epub 2019 Dec 16.
Biochem Biophys Res Commun. 2020.
PMID: 31837803